臨床外科72巻10号

2017年10月発行

特集 Conversion Surgery—進行消化器がんのトータル治療戦略

がん種別Conversion Surgeryの戦略

転移性肝癌

著者： 齋藤裕¹ 森根裕二¹ 居村暁¹ 池本哲也¹ 東島潤¹ 島田光生¹

所属機関： ¹徳島大学消化器・移植外科

ページ範囲：P.1211 - P.1216

文献概要

【ポイント】
◆推奨レジメンと至適期間：FOLFOXIRI療法を用いて，できるだけ早期（6コース以内）に効果判定し，conversionの可能性を探る．
◆切除可能とする判断根拠：ESMO consensus guideline 2016では，腫瘍学・手術手技の両面から切除可能な基準を設けるべきとされているが，確固たるコンセンスはない．

参考文献

1）大腸癌研究会：大腸癌診療ガイドライン 医師用2016年度版．金原出版，2016，pp 22-24

2）Adam R, Wicherts DA, de Haas RJ, et al：Patients with initially unresectable colorectal liver metastases：is there a possibility of cure? J Clin Oncol 27：1829-1835, 2009

3）Huguet F, Andre T, Hammel P, et al：Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase Ⅱ and Ⅲ studies. J Clin Oncol 25：326-331, 2007

4）Van Cutsem E, Kohne CH, Lang I, et al：Cetuximab plus irinotecan, fluorouracil, and leucovorin as first line treatment for metastatic colorectal cancer：updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J Clin Oncol 29：2011-2019, 2011

5）Bokemeyer C, Bondarenko I, Hartmann JT, et al：Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer：the OPUS study. Ann Oncol 22：1535-1546, 2011

6）Douillard JY, Siena S, Cassidy J, et al：Randomized, phase Ⅲ trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin（FOLFOX4）versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer：the PRIME study. J Clin Oncol 28：4697-4705, 2010

7）Folprecht G, Gruenberger T, Bechstein WO, et al：Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab：the CELIM randomised phase 2 trial. Lancet Oncol 11：38-47, 2010

8）Falcone A, Ricci S, Brunetti I, et al：Phase Ⅲ trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan（FOLFOXIRI）compared with infusional fluorouracil, leucovorin, and irinotecan（FOLFIRI）as first-line treatment for metastatic colorectal cancer：the Gruppo Oncologico Nord Ovest. J Clin Oncol 25：1670-1676, 2007

9）Cremolini C, Loupakis F, Antoniotti C, et al：Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab：results from phase Ⅲ TRIBE trial by the Gruppo Oncologico del Nord Ovest. Ann Oncol 26：1188-1194, 2015

10）Gruenberger T, Bridgewater J, Chau I, et al：Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer：the OLIVIA multinational randomised phase Ⅱ trial. Ann Oncol 26：702-708, 2015

11）Rubbia-Brandt L, Audard V, Sartoretti P, et al：Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15：460-466, 2004

12）Morine Y, Shimada M, Utsunomiya T, et al：Evaluation and management of hepatic injury induced by oxaliplatin-based chemotherapy in patients with hepatic resection for colorectal liver metastasis. Hepatol Res 44：59-69, 2014

13）Nakano H, Oussoultzoglou E, Rosso E, et al：Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 247：118-124, 2008

14）Portier G, Elias D, Bouche O, et al：Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases：FFCD ACHBTH AURC 9002 trial. J Clin Oncol 24：4976-4982, 2006

15）Nordlinger B, Van Cutsem E, Gruenberger T, et al：Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases：recommendations from an expert panel. Ann Oncol 20：985-992, 2009

16）Van Cutsem E, Cervantes A, Adam R, et al：ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 27：1386-1422, 2016

17）Beppu T, Sakamoto Y, Hasegawa K, et al：A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection：multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci, 2012